Adagene Inc. - ADAG
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 18, 2026 | SCHEDULE 13G | Chernett Jorey | 5.1% | 2,389,060 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | General Atlantic Singapore Fund Pte. Ltd. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | General Atlantic Singapore Interholdco Ltd. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | General Atlantic Partners (Bermuda) IV, L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | General Atlantic Partners (Bermuda) EU, L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | General Atlantic GenPar (Bermuda), L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | GAP (Bermuda) L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | GENERAL ATLANTIC, L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | GAP Coinvestments III, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | GAP Coinvestments IV, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | GAP Coinvestments V, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | GAP Coinvestments CDA, L.P. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | General Atlantic Partners (Lux) SCSp | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | General Atlantic GenPar (Lux) SCSp | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | General Atlantic (Lux) S.a r.l. | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | General Atlantic Singapore AI Pte. Ltd. | 0.0% | 0 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | Smith Vincent C | 8.7% | 5,095,351 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | The Vincent C. Smith, Jr. 2025 Annuity Trust | 6.1% | 3,608,019 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | VCS Master Holdings GP | 1.0% | 185,701 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | WuXi PharmaTech Healthcare Fund I L.P. | 7.0% | 4,121,815 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | WuXi AppTec Co., Ltd. | 7.0% | 4,121,815 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Panacea Venture Healthcare Fund II, L.P. | 3.8% | 2,250,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Panacea Venture Healthcare Fund II GP Company, Ltd. | 3.8% | 2,250,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Panacea Innovation Limited | 3.8% | 2,250,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | James Huang | 3.8% | 2,250,000 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.